Your account is not claimed yet. You can sign up with ORCID to claim your account.

Lingyun Ji

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Clinical trials (London, England)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pharmaceutical statistics

University of Southern California

University of Southern California (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Southern California

United States

Assistant Professor of Clinical Preventive Medicine :: Department of Preventive Medicine

Education History

University of Southern California

United States

PHD :: Department of Preventive Medicine

Publications

Karen R Rabin, Meenakshi Devidas, Zhiguo Chen, Lingyun Ji, John Kairalla, Johann K Hitzler, Jun J Yang, Andrew J Carroll, Nyla A Heerema, Michael J Borowitz, Brent L Wood, Kathryn G Roberts, Charles G Mullighan, Richard C Harvey, I-Ming Chen, Cheryl L Willman, Shalini C Reshmi, Julie M Gastier-Foster, Deepa Bhojwani, Susan R Rheingold, Kelly W Maloney, Leonard A Mattano, Eric C Larsen, Reuven J Schore, Michael J Burke, Wanda L Salzer, Naomi J Winick, William L Carroll, Elizabeth A Raetz, Mignon L Loh, Stephen P Hunger, Anne L Angiolillo
Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lingyun Ji, Todd A Alonzo
Comparison of design methods for a safety run-in phase of a phase II clinical trial. Clinical trials (London, England) (2023)
Lingyun Ji, Todd A Alonzo
Comparison of design methods for a safety run-in phase of a phase II clinical trial. Clinical trials (London, England) 20 (2) (2023)
Lingyun Ji, Todd A Alonzo
Comparison of design methods for a safety run-in phase of a phase II clinical trial. Clinical trials (London, England) (2023)
Laura E Hogan, Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J Borowitz, Elizabeth A Raetz, Andrew J Carroll, Nyla A Heerema, Gerhard Zugmaier, Elad Sharon, Melanie Brooke Bernhardt, Stephanie A Terezakis, Lia Gore, James A Whitlock, Stephen P Hunger, Mignon L Loh
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lingyun Ji, Todd A Alonzo
Comparison of design methods for a safety run-in phase of a phase II clinical trial. Clinical trials (London, England) 20 (2) (2023)
Maureen M O'Brien, Lingyun Ji, Nirali N Shah, Susan R Rheingold, Deepa Bhojwani, Constance M Yuan, Xinxin Xu, Joanna S Yi, Andrew C Harris, Patrick A Brown, Michael J Borowitz, Olga Militano, John Kairalla, Meenakshi Devidas, Elizabeth A Raetz, Lia Gore, Mignon L Loh
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (9) (2022)
Steven G DuBois, Meaghan P Granger, Susan Groshen, Denice Tsao-Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G Villablanca, Kieuhoa T Vo, Navin R Pinto, Yael P Mosse, John M Maris, Suzanne Shusterman, Susan L Cohn, Kelly C Goldsmith, Brian D Weiss, Gregory A Yanik, Clare J Twist, Meredith S Irwin, Daphne A Haas-Kogan, Julie R Park, Araz Marachelian, Katherine K Matthay
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Lingyun Ji, Lisa M McShane, Mark Krailo, Richard Sposto
Bias in retrospective analyses of biomarker effect using data from an outcome-adaptive randomized trial. Clinical trials (London, England) 16 (6) (2019)
Lingyun Ji, Lisa M McShane, Mark Krailo, Richard Sposto
Rejoinder. Clinical trials (London, England) 16 (6) (2019)
Lingyun Ji, Juan Pablo Lewinger, Mark Krailo, Susan Groshen, David V Conti, Shahab Asgharzadeh, Richard Sposto
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method. Pharmaceutical statistics 18 (6) (2019)

Lingyun Ji.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lingyun Ji